The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Targeted anti-mitotic therapies: can we improve on tubulin agents?
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Small Molecule Inhibitor of Mitotic Spindle Bipolarity Identified in a Phenotype-Based Screen
Mayer, T. U., Kapoor, T. M., Haggarty, S. J., King, R. W., Schreiber, S. L., & Mitchison, T. J. (1999) · Science · doi:10.1126/science.286.5441.971 · Cited by 1,727
Cell death by mitotic catastrophe: a molecular definition
Castedo, M., Perfettini, J.-L., Roumier, T., Andreau, K., Medema, R., & Kroemer, G. (2004) · Oncogene · doi:10.1038/sj.onc.1207528 · Cited by 1,269
Ditchfield, C., Johnson, V. L., Tighe, A., Ellston, R., Haworth, C., Johnson, T., Mortlock, A., Keen, N., & Taylor, S. S. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200208091 · Cited by 1,194
Hauf, S., Cole, R. W., LaTerra, S., Zimmer, C., Schnapp, G., Walter, R., Heckel, A., van Meel, J., Rieder, C. L., & Peters, J.-M. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200208092 · Cited by 1,155
Polo-like kinases and the orchestration of cell division
Barr, F. A., Silljé, H. H. W., & Nigg, E. A. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1401 · Cited by 1,087
Cleveland, D. W., Mao, Y., & Sullivan, K. F. (2003) · Cell · doi:10.1016/s0092-8674(03)00115-6 · Cited by 1,003
Blangy, A., Lane, H. A., d'Hérin, P., Harper, M., Kress, M., & Niggt, E. A. (1995) · Cell · doi:10.1016/0092-8674(95)90142-6 · Cited by 952
Chang, J. C., Wooten, E. C., Tsimelzon, A., Hilsenbeck, S. G., Gutierrez, M. C., Elledge, R., Mohsin, S., Osborne, C. K., Chamness, G. C., Allred, D. C., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14023-8 · Cited by 875
Targeting polo-like kinase 1 for cancer therapy
Strebhardt, K., & Ullrich, A. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1841 · Cited by 841
Jordan, M. A., Wendell, K., Gardiner, S., Derry, W. B., Copp, H., & Wilson, L. (1996) · PubMed · Cited by 770
Aurora-A — A guardian of poles
Marumoto, T., Zhang, D., & Saya, H. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1526 · Cited by 697
Hanna, N., Bunn, P. A., Langer, C., Einhorn, L., Guthrie, T., Beck, T., Ansari, R., Ellis, P., Byrne, M., Morrison, M., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.8595 · Cited by 681
Aurora-kinase inhibitors as anticancer agents
Keen, N., & Taylor, S. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1502 · Cited by 675
Gianni, L., Zambetti, M., Clark, K., Baker, J., Cronin, M., Wu, J., Mariani, G., Rodriguez, J., Carcangiu, M., Watson, D., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.0818 · Cited by 626
Polo-like kinase (Plk)1 depletion induces apoptosis in cancer cells
Liu, X., & Erikson, R. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1031523100 · Cited by 472
Adams, R. R., Maiato, H., Earnshaw, W. C., & Carmena, M. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.4.865 · Cited by 453
Chromosomes Can Congress to the Metaphase Plate Before Biorientation
Kapoor, T. M., Lampson, M. A., Hergert, P., Cameron, L., Cimini, D., Salmon, E. D., McEwen, B. F., & Khodjakov, A. (2006) · Science · doi:10.1126/science.1122142 · Cited by 439
Kops, G. J. P. L., Foltz, D. R., & Cleveland, D. W. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401142101 · Cited by 437
CENP-E is a plus end-directed kinetochore motor required for metaphase chromosome alignment
Wood, K. W., Sakowicz, R., Goldstein, L. S. B., & Cleveland, D. W. (1997) · Cell · doi:10.1016/s0092-8674(00)80419-5 · Cited by 431
Aurora-A kinase is required for centrosome maturation in Caenorhabditis elegans
Hannak, E., Kirkham, M., Hyman, A. A., & Oegema, K. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200108051 · Cited by 422
Yao, X., Abrieu, A., Zheng, Y., Sullivan, K. F., & Cleveland, D. W. (2000) · Nature Cell Biology · doi:10.1038/35019518 · Cited by 391
Polo-like kinases (Plks) and cancer
Takai, N., Hamanaka, R., Yoshimatsu, J., & Miyakawa, I. (2005) · Oncogene · doi:10.1038/sj.onc.1208272 · Cited by 386
Chan, G. K. T., Jablonski, S. A., Sudakin, V., Hittle, J. C., & Yen, T. J. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.146.5.941 · Cited by 376
Polo-like kinases and oncogenesis
Eckerdt, F., Yuan, J., & Strebhardt, K. (2005) · Oncogene · doi:10.1038/sj.onc.1208273 · Cited by 365
Roles of Polo-like Kinase 1 in the Assembly of Functional Mitotic Spindles
Sumara, I., Giménez-Abián, J. F., Gerlich, D., Hirota, T., Kraft, C., de la Torre, C., Ellenberg, J., & Peters, J.-M. (2004) · Current Biology · doi:10.1016/j.cub.2004.09.049 · Cited by 345
Giet, R., McLean, D., Descamps, S., Lee, M. J., Raff, J. W., Prigent, C., & Glover, D. M. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200108135 · Cited by 331
Unstable Kinetochore-Microtubule Capture and Chromosomal Instability Following Deletion of CENP-E
Putkey, F. R., Cramer, T., Morphew, M. K., Silk, A. D., Johnson, R. S., McIntosh, J. R., & Cleveland, D. W. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00255-1 · Cited by 329
CENP-E Function at Kinetochores Is Essential for Chromosome Alignment
Schaar, B. T., Chan, G. K. T., Maddox, P., Salmon, E. D., & Yen, T. J. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.6.1373 · Cited by 324
Mondesire, W. H., Jian, W., Zhang, H., Ensor, J., Hung, M.-C., Mills, G. B., & Meric-Bernstam, F. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0361 · Cited by 319
Phase II Study of Erlotinib in Patients With Advanced Biliary Cancer
Philip, P. A., Mahoney, M. R., Allmer, C., Thomas, J., Pitot, H. C., Kim, G., Donehower, R. C., Fitch, T., Picus, J., & Erlichman, C. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.3579 · Cited by 318
Tao, W., South, V. J., Zhang, Y., Davide, J. P., Farrell, L., Kohl, N. E., Sepp-Lorenzino, L., & Lobell, R. B. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.06.003 · Cited by 273
McEwen, B. F., Chan, G. K. T., Zubrowski, B., Savoian, M. S., Sauer, M. T., & Yen, T. J. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.9.2776 · Cited by 271
Mitotic mechanics: the auroras come into view
Andrews, P. D., Knatko, E., Moore, W. J., & Swedlow, J. R. (2003) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2003.10.013 · Cited by 268
Past and future of the mitotic spindle as an oncology target
Wood, K. (2001) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(01)00064-9 · Cited by 244
Antitumor Activity of a Kinesin Inhibitor
Sakowicz, R., Finer, J. T., Beraud, C., Crompton, A., Lewis, E., Fritsch, A., Lee, Y., Mak, J., Moody, R., Turincio, R., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3839 · Cited by 241
Mao, Y., Abrieu, A., & Cleveland, D. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00475-6 · Cited by 241
CENP-E as an Essential Component of the Mitotic Checkpoint In Vitro
Abrieu, A., Kahana, J. A., Wood, K. W., & Cleveland, D. W. (2000) · Cell · doi:10.1016/s0092-8674(00)00070-2 · Cited by 239
Yao, X., Anderson, K. L., & Cleveland, D. W. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.2.435 · Cited by 232
DeBonis, S., Skoufias, D. A., Lebeau, L., Lopez, R., Robin, G., Margolis, R. L., Wade, R. H., & Kozielski, F. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1079.3.9 · Cited by 215
Inhibition of a Mitotic Motor Protein: Where, How, and Conformational Consequences
Yan, Y., Sardana, V., Xu, B., Homnick, C., Halczenko, W., Buser, C. A., Schaber, M., Hartman, G. D., Huber, H. E., & Kuo, L. C. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2003.10.074 · Cited by 205
Michel, L., Diaz-Rodriguez, E., Narayan, G., Hernando, E., Murty, V. V. V. S., & Benezra, R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306069101 · Cited by 188
Gizatullin, F., Yao, Y., Kung, V., Harding, M. W., Loda, M., & Shapiro, G. I. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3353 · Cited by 178
Marcus, A. I., Peters, U., Thomas, S. L., Garrett, S., Zelnak, A., Kapoor, T. M., & Giannakakou, P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413471200 · Cited by 170
Holmes, F. A., Madden, T., Newman, R. A., Valero, V, Theriault, R. L., Fraschini, G., Walters, R. S., Booser, D. J., Buzdar, A. U., Willey, J., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.10.2713 · Cited by 164
PHA-680632, a Novel Aurora Kinase Inhibitor with Potent Antitumoral Activity
Soncini, C., Carpinelli, P., Gianellini, L., Fancelli, D., Vianello, P., Rusconi, L., Storici, P., Zugnoni, P., Pesenti, E., Croci, V., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1964 · Cited by 162
Development and Biological Evaluation of Potent and Specific Inhibitors of Mitotic Kinesin Eg5
Gärtner, M., Sunder‐Plassmann, N., Seiler, J., Utz, M., Vernos, I., Surrey, T., & Giannis, A. (2005) · ChemBioChem · doi:10.1002/cbic.200500005 · Cited by 154
Cox, C. D., Breslin, M. J., Mariano, B. J., Coleman, P. J., Buser, C. A., Walsh, E. S., Hamilton, K., Huber, H. E., Kohl, N. E., Torrent, M., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.02.055 · Cited by 139
The bimC family of kinesins: essential bipolar mitotic motors driving centrosome separation
Kashina, A. S., Rogers, G. C., & Scholey, J. M. (1997) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(97)00037-2 · Cited by 131
Mitotic requirement for aurora A kinase is bypassed in the absence of aurora B kinase
Yang, H., Burke, T. F., Dempsey, J. A., Diaz, B., Collins, E., Toth, J. E., Beckmann, R. P., & Ye, X. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.04.080 · Cited by 116
Brier, S., Lemaire, D., DeBonis, S., Forest, É., & Kozielski, F. (2004) · Biochemistry · doi:10.1021/bi049264e · Cited by 109
Dominant-negative polo-like kinase 1 induces mitotic catastrophe independent of cdc25C function.
Cogswell, J. P., Brown, C. E., Bisi, J., & Neill, S. D. (2000) · PubMed · Cited by 101
Nigg, E. A., Blangy, A., & Lane, H. A. (1996) · Experimental Cell Research · doi:10.1006/excr.1996.0356 · Cited by 92
Aurora A and B kinases as targets for cancer: will they be selective for tumors?
Matthews, N., Visintin, C., Hartzoulakis, B., Jarvis, A., & Selwood, D. L. (2006) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.6.1.109 · Cited by 76
Crystal Structure of the Motor Domain of the Human Kinetochore Protein CENP-E
Garcia-Saez, I., Yen, T. J., Wade, R. H., & Kozielski, F. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.05.053 · Cited by 61
Rubin, E. H., Shapiro, G. I., Stein, M. N., Watson, P., Bergstrom, D. A., Xiao, A., Clark, J., Freedman, S. J., & Eder, J. P. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.24.18_suppl.3009 · Cited by 48
Komatsu, M., Hiyama, K., Tanimoto, K., Yunokawa, M., Otani, K., Ohtaki, M., Hiyama, E., Kigawa, J., Ohwada, M., Suzuki, M., et al. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0408 · Cited by 30
The Bereavement Visit in Pediatric Oncology
Stein, J., Bortz, A. P., Buchval, I., Klein, A., & Yaniv, I. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.05.005 · Cited by 21
Cited by
Gascoigne, K. E., & Taylor, S. S. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.07.002 · Cited by 832
Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7
Wertz, I. E., Kusam, S., Lam, C., Okamoto, T., Sandoval, W., Anderson, D. J., Helgason, E., Ernst, J. A., Eby, M., Liu, J., et al. (2011) · Nature · doi:10.1038/nature09779 · Cited by 794
Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy
Strebhardt, K. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3184 · Cited by 653
Gujrati, V., Kim, S., Kim, S.-H., Min, J. J., Choy, H. E., Kim, S. C., & Jon, S. (2014) · ACS Nano · doi:10.1021/nn405724x · Cited by 543
Rath, O., & Kozielski, F. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3310 · Cited by 496
Metadata
- Authors
- Jackson, J. R., Patrick, D. R., Dar, M. M., & Huang, P. S.
- Venue
- Nature Reviews Cancer
- Published
- 2007-02
- Volume
- 7
- Issue
- 2
- Pages
- 107-117
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2080849052
- Cited by
- 473
- References
- 57
- FWCI
- 1.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.